76330-26-2Relevant academic research and scientific papers
Synthesis and reactions of 3-aminothiazolidine-2-thion-4-one derivatives. 3. Reaction of 3-[N-(α-methylthio)ethylidene] aminothiazolidine-2-thion-4-one with amines
Mikitenko,Romanov,Shpileva
, p. 244 - 247 (1981)
It is shown that recyclization leading to the formation of 1,3,4-thiadiazole derivatives occurs in the reaction of 3-[N-(α-methylthio)ethylidene]aminothiazolidine-2-thion-4-one with amines. The structures of the compounds obtained were established by spec
Synthesis and Structure–Activity Relationship of Thioacetamide-Triazoles against Escherichia coli
Bulitta, Jürgen B.,Dharuman, Suresh,Lee, Richard E.,Reeve, Stephanie M.,Wallace, Miranda J.
, (2022/03/01)
Infections due to Gram-negative bacteria are increasingly dangerous due to the spread of multi-drug resistant strains, emphasizing the urgent need for new antibiotics with alternative modes of action. We have previously identified a novel class of antibacterial agents, thioacetamide-triazoles, using an antifolate targeted screen and determined their mode of action which is dependent on activation by cysteine synthase A. Herein, we report a detailed examination of the anti-E. coli structure–activity relationship of the thioacetamide-triazoles. Analogs of the initial hit compounds were synthesized to study the contribution of the aryl, thioacetamide, and triazole sections. A clear structure–activity relationship was observed generating compounds with excellent inhibition values. Substitutions to the aryl ring were generally best tolerated, including the introduction of thiazole and pyridine heteroaryl systems. Substitutions to the central thioacetamide linker section were more nuanced; the introduction of a methyl branch to the thioacetamide linker substantially decreased antibacterial activity, but the isomeric propionamide and N-benzamide systems retained activity. Changes to the triazole portion of the molecule dramatically decreased the antibacterial activity, further indicating that 1,2,3-triazole is critical for potency. From these studies, we have identified new lead compounds with desirable in-vitro ADME properties and in-vivo pharmacokinetic properties.
